Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.0205074 on May 27, 2005

Published online before print May 27, 2005
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.0205074v1
78/3/585    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNeil, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, S. E.
(Journal of Leukocyte Biology. 2005;78:585-594.)
© 2005 by Society for Leukocyte Biology

Nanotechnology for the biologist

Scott E. McNeil1

SAIC-Frederick, Nanotechnology Characterization Laboratory, Frederick, Maryland

1Correspondence: SAIC-Frederick, Nanotechnology Characterization Laboratory, 1050 Boyles St., Frederick, MD 21702-1201. E-mail: mcneils{at}ncifcrf.gov

Nanotechnology refers to research and technology development at the atomic, molecular, and macromolecular scale, leading to the controlled manipulation and study of structures and devices with length scales in the 1- to 100-nanometers range. Objects at this scale, such as "nanoparticles," take on novel properties and functions that differ markedly from those seen in the bulk scale. The small size, surface tailorability, improved solubility, and multifunctionality of nanoparticles open many new research avenues for biologists. The novel properties of nanomaterials offer the ability to interact with complex biological functions in new ways—operating at the very scale of biomolecules. This rapidly growing field allows cross-disciplinary researchers the opportunity to design and develop multifunctional nanoparticles that can target, diagnose, and treat diseases such as cancer. This article presents an overview of nanotechnology for the biologist and discusses "nanotech" strategies and constructs that have already demonstrated in vitro and in vivo efficacy.

Key Words: nanoparticle • anticancer drug • drug delivery • polyethylene glycol




This article has been cited by other articles:


Home page
 Cancer Res.Home page
O. Veiseh, C. Sun, C. Fang, N. Bhattarai, J. Gunn, F. Kievit, K. Du, B. Pullar, D. Lee, R. G. Ellenbogen, et al.
Specific Targeting of Brain Tumors with an Optical/Magnetic Resonance Imaging Nanoprobe across the Blood-Brain Barrier
Cancer Res., August 1, 2009; 69(15): 6200 - 6207.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Dey, V. Bakthavatchalu, M. T. Tseng, P. Wu, R. L. Florence, E. A. Grulke, R. A. Yokel, S. K. Dhar, H.-S. Yang, Y. Chen, et al.
Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells
Carcinogenesis, October 1, 2008; 29(10): 1920 - 1929.
[Abstract] [Full Text] [PDF]